“…In the last decade, organic and pharmaceutical researchers have especially focused on antipyrine derivatives which possess a broad spectrum of therapeutic and clinical applications. Moreover, there are some antipyrine-based commercially available drugs such as Famprofazone and Edaravone ( Sahoo et al, 2020 , Ebosie et al, 2021 , Mustafa et al, 2022 , Shaikh et al, 2023 ). In 2023, Al-Sanea and co-workers prepared an oxadiazolyl linked to antipyrine derivative I , which demonstrated anti-inflammatory activity and selective inhibitory activity against COX-2 enzymes ( Al-Sanea et al, 2023 ).…”